Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q2 2020 · 10-Q
Revenue$125.00K$125.00K±0.0% vs Q2 2019 Net Income-$5.34M-$5.34MN/M vs Q2 2019 EPS Diluted-$0.18-$0.18N/M vs Q2 2019 Operating Income-$4,766,997N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,951,811N/M Margins · derivedOperating margin-3813.6%+642.2 pt vs Q2 2019
Net margin-4274.3%+449.3 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 14, 2020 · 45 d after period end